| Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For Decades T Amin, A Kesselheim Health Affairs, 2012 | 93 | 2012 |
| Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India S Padmanabhan, T Amin, B Sampat, R Cook-Deegan, ... Nature biotechnology 28 (7), 671-678, 2010 | 69 | 2010 |
| Challenges to India's pharmaceutical patent laws BN Sampat, KC Shadlen, TM Amin Science 337 (6093), 414-415, 2012 | 33 | 2012 |
| Voluntary licensing practices in the pharmaceutical sector: an acceptable solution to improving access to affordable medicines T Amin | 31 | 2007 |
| Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of … S Chandrasekharan, T Amin, J Kim, E Furrer, AC Matterson, N Schwalbe, ... Vaccine 33 (46), 6366-6370, 2015 | 22 | 2015 |
| Patents (amendment) bill 2005: A critique KM Gopakumar, T Amin Economic and Political Weekly, 1503-1505, 2005 | 22 | 2005 |
| Re-visiting the patents and access to medicines dichotomy: An evaluation of TRIPS implementation and public health safeguards in developing countries T Amin The Global Governance of HIV/AIDS, 109-130, 2013 | 13 | 2013 |
| A global intellectual property waiver is still needed to address the inequities of COVID-19 and future pandemic preparedness T Amin, AS Kesselheim INQUIRY: The Journal of Health Care Organization, Provision, and Financing …, 2022 | 12 | 2022 |
| How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice? BN Sampat, T Amin Journal of health politics, policy and law 38 (4), 735-755, 2013 | 11 | 2013 |
| Patents and clean energy: bridging the gap between evidence and policy K Karachalios, N Thumm, A Abdel Latif, R Roffe, B Simmons, T Amin Final Report. Joint Report of the United Nations Environment Programme (UNEP …, 2010 | 9 | 2010 |
| Expert Review Of Drug Patent Applications: Improving Health In The Developing World: Engaging outside experts in patent review could curtail the granting of unmerited patents … T Amin, R Rajkumar, P Radhakrishnan, AS Kesselheim Health Affairs 28 (Suppl1), w948-w956, 2009 | 7 | 2009 |
| Taming of the Flu: Working through the Tamiflu patents in India S Basheer, T Amin Journal of Intellectual Property Rights 2, 113, 2006 | 6 | 2006 |
| The folly of hoarding knowledge in the COVID-19 age: Let vaccine producers in poor countries help end the pandemic T Amin Foreign Affairs 29, 2021 | 4 | 2021 |
| Searching for transparency: Improving patent information to increase access to medicines T Amin Bridges 14 (4), 2010 | 4 | 2010 |
| India’s Patent Act on Trial T Amin BRIDGES 11 (1), 15, 2007 | 4 | 2007 |
| The impact of Article 39.3 in India: a practical perspective T Amin, VH Devaiah, P Radhakrishnan, M Steffen Available at SSRN 3030727, 2006 | 3 | 2006 |
| Voluntary licensing practices in the pharmaceutical sector: An acceptable solution to improving access to affordable medicines?[Internet][consultado el 2 de febrero del 2016] T Amin Disponible sur: http://static1 1, 0 | 3 | |
| Innovation alone won’t end COVID-19 T Amin Nature Human Behaviour 6 (2), 172-173, 2022 | 2 | 2022 |
| Whether and How the US Government Should Exercise Its Compulsory Licensing Authority under 28 USC Sec. 1498 and the Bayh-Dole Act A Rai, RS Eisenberg, T Amin, H Hadad, R Sachs NYU J. Intell. Prop. & Ent. L. 11, 38, 2021 | 1 | 2021 |
| Addressing Drug Patent Abuse: Restoring The Role Of Inter Partes Review T Amin Health Affairs Forefront, 2022 | | 2022 |
